Free Trial

Enanta Pharmaceuticals (ENTA) SEC Filings & 10K Form

$12.15
+0.11 (+0.91%)
(As of 11:06 AM ET)

Recent Enanta Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/09/2024
4:24 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:00 PM
Enanta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
4:29 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
4:30 PM
Enanta Pharmaceuticals (Subject)
Rottinghaus Scott T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
7:38 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:23 PM
Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:27 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:30 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:15 PM
Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:19 PM
Enanta Pharmaceuticals (Issuer)
Hata Yujiro S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:12 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:31 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:11 PM
Enanta Pharmaceuticals (Subject)
Krensavage Asset Management, LLC (Filed by)
Form SCHEDULE 13G
02/14/2024
7:21 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:23 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:00 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:09 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:12 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:15 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:18 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
11:15 PM
Enanta Pharmaceuticals (Filer)
Form EFFECT
01/26/2024
8:11 AM
Enanta Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
01/24/2024
4:23 PM
BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/22/2024
11:25 AM
Enanta Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/11/2024
3:15 PM
Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
12/15/2023
7:08 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:16 PM
Enanta Pharmaceuticals (Subject)
Vance Terry (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
7:26 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:29 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:31 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:17 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:19 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:22 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:24 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:24 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:08 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:11 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:15 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:19 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:21 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trader Books $13M Profit on “Nvidia of Crypto” (Ad)

A position trader recently booked an estimated $13.2 million profit on a single crypto currency… This little-known coin, dubbed the "Nvidia of crypto," is fueling the artificial intelligence boom – allowing top companies to train their AI systems without the need for expensive microchips.

Click here to review my research and the strategy I've developed for the opportunity to trade this c
11/22/2023
4:10 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:10 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:11 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:11 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:38 PM
Enanta Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/22/2023
3:12 PM
Enanta Pharmaceuticals (Filer)
Form POSASR
11/22/2023
3:21 PM
Enanta Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/16/2023
3:31 PM
Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
10/06/2023
1:34 PM
BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ENTA) was last updated on 9/12/2024 by MarketBeat.com Staff

From Our Partners